Polytas B 500000IU Injection
Marketer
Aequitas Healthcare Pvt Ltd
Salt Composition
Polymyxin B (500000IU)
Overview Polytas B 500000IU Injection
High-dose Polytas B (500,000 IU) injection is a potent antibacterial agent indicated for the management of serious systemic bacterial infections. Its mechanism involves both bacterial eradication and growth inhibition. This medication is frequently administered to hospitalized patients in critical condition. Administration must be under the direction of a medical professional, with consistent daily dosing for optimal efficacy. The prescribed course of treatment should be completed fully, even with rapid symptom improvement; premature discontinuation risks relapse or infection exacerbation. Potential adverse events, including severe allergic reactions (anaphylaxis), nephrotoxicity, neurotoxicity, pyrexia, and local injection site reactions (pain, erythema, edema), may occur. These reactions are generally transient and resolve with continued therapy. Persistent or bothersome side effects warrant immediate medical consultation. Prior to commencing therapy, patients should disclose any antibiotic allergies, pre-existing hepatic or renal impairment. Pregnant individuals require specific physician consultation before initiating treatment. Regular blood tests to assess renal function may be implemented by your doctor.
Uses of Polytas B 500000IU Injection
Managing life-threatening bacterial infections
Major Benefits of Polytas B 500000IU Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
Common Side effects of Polytas B 500000IU Injection:
- Anaphylactic reaction
- Fever
- Kidney damage
- Neurotoxicity
- Injection site reactions (pain, swelling, redness)
How to use Polytas B 500000IU Injection:
This medication will be administered by your physician or registered nurse; self-medication is strictly prohibited.
How Polytas B 500000IU Injection works:
Polytas B 500000IU Injection is a bactericidal antibiotic that disrupts bacterial cell membranes, leading to cell death.
SAFETY ADVICE
AlcoholSAFE
There are no known adverse reactions associated with the concomitant use of alcohol and Polytas B 500000IU Injection.
PregnancyCONSULT YOUR DOCTOR
The use of Polytas B 500000IU Injection during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a fetus. A physician will assess the potential advantages against the risks prior to prescribing. Seek medical advice.
Breast feedingSAFE IF PRESCRIBED
Administration of Polytas B 500000IU Injection while breastfeeding appears to pose minimal risk. Available human data indicates negligible infant hazard.
DrivingUNSAFE
Following administration of Polytas B 500000IU Injection, temporary blurred vision may occur. Refrain from driving until your vision returns to normal.
KidneyCONSULT YOUR DOCTOR
Data regarding Polytas B 500000IU Injection's use in individuals with renal impairment is scarce. Physician consultation is advised.
LiverCONSULT YOUR DOCTOR
Insufficient data exists regarding the administration of Polytas B 500000IU Injection to individuals with hepatic impairment. Physician consultation is advised.
What if you forget to take Polytas B 500000IU Injection :
NA
Facts to Know About Polytas B 500000IU Injection
| Label | Value |
|---|---|
| Type of Compound | Polymyxin antibiotics |
| Potential for Dependence | None. |
| Medication Classification | Eye and ear medications |
| Mechanism of Action | Membrane-targeting drug |
3,018 People bought this recently